NF-κB is a critical regulator of the survival of rodent and human hepatic myofibroblasts

These data highlight the conserved role of NF-κB during fibrogenesis. Our data validate the use of rodent models for pre-clinical testing of NF-κB inhibitors as anti-fibrotics and stimulators of fibrotic extracellular matrix remodelling.